• Eisai Company, Ltd. (ESALY.PK) and Toyama Chemical Company Receive Approval to Market Anti-rheumatic Agent Iguratimod in Japan More...

• Ipsen's Somatuline Gets Marketing Approval in Japan More...

• Bedford Laboratories Issues Voluntary Drug Recall More...

• FDA Approves Actelion Pharmaceuticals US, Inc. (ATLN.VX)'s SNDA for Second Generation VELETRI for Injection More...

• BioDelivery Sciences International (BDSI) Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study More...

• A.P. Pharma, Inc. (APPA) Announces Positive APF530 Patient-Satisfaction Data from Phase 3 Study in Patients With Chemotherapy-Induced Nausea and Vomiting More...

• Medivir AB (MVIRb.F) Announces an Interferon-Free Phase II Combination Trial With TMC435 and Daclatasvir to Commence Shortly More...

• Lexicon Pharmaceuticals, Inc. (LXRX) Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics More...

• PROLOR Biotech (PBTH) to Present Data on Its Long-Acting Clotting Factors at Leading International Scientific Conference More...

• Why a Change in a Bristol-Myers Squibb Company (BMY) Hepatitis C Trial Has Big Implications More...

• Eating Vegetables May Protect Pancreas, Karolinska Institute Study More...

• Smallest, Largest Fetuses at Higher Risk of Stillbirth, St. Michael's Hospital StudyMore...

• Weill Cornell Medical College Study Affirms Safety and Acceptability of Shang Ring for Reducing HIV Risk Among Men More...

• NemoursStudy Shows Fruit and Vegetable Juice Concentrate May Reduce Abdominal Fat Mass and Improve Insulin Resistance in Overweight Boys More...

• MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Receives Notice of Patent Allowance Covering Fat Stem Cell Therapy of Autoimmune Diseases More...

• Osiris Therapeutics, Inc. (OSIR) Bolsters its Stem Cell Intellectual Property Estate More...

• InterMune, Inc. (ITMN) Release: Sweden's Dental and Pharmaceutical Benefits Agency (TLV) Authorizes Reimbursement of Esbriet® (pirfenidone) More...

Biogen Idec, Inc. (Massachusetts) (BIIB), Isis Pharmaceuticals, Inc. (ISIS) Strike Deal Worth Up to $271 Million More...

• GlaxoSmithKline (GSK), UCB, Inc. (UCBJF.PK) and Eisai Inc. (ESALF.PK) in Unique National Health Service Joint Working Pact More...

• Abaxis, Inc. (ABAX) Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial More...

• Merrimack Pharmaceuticals Inc. and Cancer Treatment Centers Of America Partner in Multifaceted Collaboration to Advance Translational Research and Individualized Treatment More...

• Selvita and Orion Pharma Achieve a Research Milestone in Alzheimer's Disease Program More...

• BioInvent (BOVNF) Cuts Jobs, Reorganizes More...

• Redx Pharma to Create 119 New Jobs in Liverpool More...

• Ohr Pharmaceutical (OHRP) Announces $2.9 Million Financing More...

• GlaxoSmithKline (GSK) Sets Time of Tender Offer to Buy Human Genome Sciences, Inc. (HGSI) to July 20 More...

• Vitrolife Acquires Cryo Management Ltd for EUR 5 Million and Thereby Broadens the Product Portfolio More...

• ILS Launches ILS Genomics Via the First Acquisition in Company History More...

• 3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology More...

• IMPAX Laboratories, Inc. (IPXL) Announces Resignation of Arthur A. Koch More...

• Becton, Dickinson and Company (BDX) Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call More...

• Charles River Laboratories (Massachusetts) Schedules Second-Quarter 2012 Earnings Release and Conference Call More...

• Oxygen Biotherapeutics, Inc. (OXBO) Sets Year-End Financial Results Conference Call and Webcast for July 25th and General Annual Meeting for August 31st More...

• Tyco International Ltd. (TYC) to Report Third Quarter Results July 31, 2012 More...

• Breckenridge Pharmaceutical, Inc. and Alembic, Limited Announce Paragraph IV ANDA Litigation with Pfizer Inc. (PFE) on Desvenlafaxine tablets (Pristiq®) More...

• ScinoPharm Invests $37.6 Milliion to Construct Injectable Cancer Drugs Plant More...

• Roche (RHHBY) Wooed by States That Want Its New East Coast R&D Center More...

• European Spallation Source AB: International Expert Panel Declares ESSProject Ready for Construction More...